Literature DB >> 32472944

Comparison of Core Features in Four Developmental Encephalopathies in the Rett Natural History Study.

Clare Cutri-French1, Dallas Armstrong2, Joni Saby3, Casey Gorman2, Jane Lane4, Cary Fu5, Sarika U Peters5, Alan Percy5, Jeffrey L Neul2, Eric D Marsh1,2.   

Abstract

OBJECTIVE: Rett syndrome, CDKL5-deficiency disorder, FOXG1 disorder, and MECP2 duplication disorder are developmental encephalopathies with shared and distinct features. Although they are historically linked, no direct comparison has been performed. The first head-to-head comparison of clinical features in these conditions is presented.
METHODS: Comprehensive clinical information was collected from 793 individuals enrolled in the Rett and Rett-Related Disorders Natural History Study. Clinical features including clinical severity, regression, and seizures were cross-sectionally compared between diagnoses to test the hypothesis that these are 4 distinct disorders.
RESULTS: Distinct patterns of clinical severity, seizure onset age, and regression were present. Individuals with CDKL5-deficency disorder were the most severely affected and had the youngest age at seizure onset (2 months), whereas children with MECP2 duplication syndrome had the oldest median age at seizure onset (64 months) and lowest severity scores. Rett syndrome and FOGX1 were intermediate in both features. Smaller head circumference correlates with increased severity in all disorders and earlier age at seizure onset in MECP2 duplication syndrome. Developmental regression occurred in all Rett syndrome participants (median = 18 months) but only 23 to 34% of the other disorders. Seizure incidence prior to the baseline visit was highest for CDKL5 deficiency disorder (96.2%) and lowest for Rett syndrome (47.5%). Other clinical features including seizure types and frequency differed among groups.
INTERPRETATION: Although these developmental encephalopathies share many clinical features, clear differences in severity, regression, and seizures warrant considering them as unique disorders. These results will aid in the development of disease-specific severity scales, precise therapeutics, and future clinical trials. ANN NEUROL 2020;88:396-406.
© 2020 American Neurological Association.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32472944      PMCID: PMC8882337          DOI: 10.1002/ana.25797

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  39 in total

1.  United States head circumference growth reference charts: birth to 21 years.

Authors:  Jonathan D Rollins; Julianne S Collins; Kenton R Holden
Journal:  J Pediatr       Date:  2010-03-20       Impact factor: 4.406

2.  British 1990 growth reference centiles for weight, height, body mass index and head circumference fitted by maximum penalized likelihood.

Authors:  T J Cole; J V Freeman; M A Preece
Journal:  Stat Med       Date:  1998-02-28       Impact factor: 2.373

Review 3.  Cyclin-Dependent Kinase-Like 5 Deficiency Disorder: Clinical Review.

Authors:  Heather E Olson; Scott T Demarest; Elia M Pestana-Knight; Lindsay C Swanson; Sumaiya Iqbal; Dennis Lal; Helen Leonard; J Helen Cross; Orrin Devinsky; Tim A Benke
Journal:  Pediatr Neurol       Date:  2019-02-23       Impact factor: 3.372

4.  Expanding the clinical picture of the MECP2 Duplication syndrome.

Authors:  Z Lim; J Downs; K Wong; C Ellaway; H Leonard
Journal:  Clin Genet       Date:  2016-07-21       Impact factor: 4.438

5.  Epilepsy in Rett syndrome--lessons from the Rett networked database.

Authors:  Andreea Nissenkorn; Rachel S Levy-Drummer; Ori Bondi; Alessandra Renieri; Laurent Villard; Francesca Mari; Maria A Mencarelli; Caterina Lo Rizzo; Ilaria Meloni; Mercedes Pineda; Judith Armstrong; Angus Clarke; Nadia Bahi-Buisson; Bosnjak Vlatka Mejaski; Milena Djuric; Dana Craiu; Alexsandra Djukic; Giorgio Pini; Anne Marie Bisgaard; Bela Melegh; Aglaia Vignoli; Silvia Russo; Cristina Anghelescu; Edvige Veneselli; Joussef Hayek; Bruria Ben-Zeev
Journal:  Epilepsia       Date:  2015-03-19       Impact factor: 5.864

Review 6.  The MECP2 duplication syndrome.

Authors:  Melissa B Ramocki; Y Jane Tavyev; Sarika U Peters
Journal:  Am J Med Genet A       Date:  2010-05       Impact factor: 2.802

Review 7.  Epilepsy in Rett syndrome, and CDKL5- and FOXG1-gene-related encephalopathies.

Authors:  Renzo Guerrini; Elena Parrini
Journal:  Epilepsia       Date:  2012-09-21       Impact factor: 5.864

8.  CDKL5 and ARX mutations in males with early-onset epilepsy.

Authors:  Ghayda M Mirzaa; Alex R Paciorkowski; Eric D Marsh; Elizabeth M Berry-Kravis; Livija Medne; Asem Alkhateeb; Art Grix; Elaine C Wirrell; Berkley R Powell; Katherine C Nickels; Barbara Burton; Andrea Paras; Katherine Kim; Wendy Chung; William B Dobyns; Soma Das
Journal:  Pediatr Neurol       Date:  2013-05       Impact factor: 3.372

9.  Phenotypic manifestations of MECP2 mutations in classical and atypical Rett syndrome.

Authors:  Carolyn Schanen; Elisa J F Houwink; Naghmeh Dorrani; Jane Lane; Ruth Everett; Alice Feng; Rita M Cantor; Alan Percy
Journal:  Am J Med Genet A       Date:  2004-04-15       Impact factor: 2.802

10.  Epilepsy in classic Rett syndrome: Course and characteristics in adult age.

Authors:  Mari Wold Henriksen; Hilde Breck; Stephen von Tetzchner; Benedicte Paus; Ola H Skjeldal; Eylert Brodtkorb
Journal:  Epilepsy Res       Date:  2018-06-23       Impact factor: 3.045

View more
  13 in total

Review 1.  CDKL5 Deficiency Disorder-Related Epilepsy: A Review of Current and Emerging Treatment.

Authors:  William Hong; Isabel Haviland; Elia Pestana-Knight; Judith L Weisenberg; Scott Demarest; Eric D Marsh; Heather E Olson
Journal:  CNS Drugs       Date:  2022-05-28       Impact factor: 6.497

2.  International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder.

Authors:  Sam Amin; Marie Monaghan; Angel Aledo-Serrano; Nadia Bahi-Buisson; Richard F Chin; Angus J Clarke; J Helen Cross; Scott Demarest; Orrin Devinsky; Jenny Downs; Elia M Pestana Knight; Heather Olson; Carol-Anne Partridge; Graham Stuart; Marina Trivisano; Sameer Zuberi; Tim A Benke
Journal:  Front Neurol       Date:  2022-06-20       Impact factor: 4.086

3.  Recommendations by the ClinGen Rett/Angelman-like expert panel for gene-specific variant interpretation methods.

Authors:  Dianalee McKnight; Lora Bean; Izabela Karbassi; Katelynn Beattie; Thierry Bienvenu; Hope Bonin; Ping Fang; John Chrisodoulou; Michael Friez; Maria Helgeson; Rahul Krishnaraj; Linyan Meng; Lindsey Mighion; Jeffrey Neul; Alan Percy; Simon Ramsden; Huda Zoghbi; Soma Das
Journal:  Hum Mutat       Date:  2021-12-02       Impact factor: 4.700

Review 4.  The Molecular Functions of MeCP2 in Rett Syndrome Pathology.

Authors:  Osman Sharifi; Dag H Yasui
Journal:  Front Genet       Date:  2021-04-23       Impact factor: 4.599

5.  Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder.

Authors:  Heather E Olson; Carolyn I Daniels; Isabel Haviland; Timothy A Benke; Annapurna Poduri; Lindsay C Swanson; Caitlin A Greene; Anne Marie M Denny; Scott T Demarest; Elia Pestana-Knight; Xiaoming Zhang; Ahsan N Moosa; Andrea Fidell; Judith L Weisenberg; Bernhard Suter; Cary Fu; Jeffrey L Neul; Alan K Percy; Eric D Marsh
Journal:  J Neurodev Disord       Date:  2021-09-16       Impact factor: 4.025

Review 6.  A brief history of MECP2 duplication syndrome: 20-years of clinical understanding.

Authors:  Daniel Ta; Jenny Downs; Gareth Baynam; Andrew Wilson; Peter Richmond; Helen Leonard
Journal:  Orphanet J Rare Dis       Date:  2022-03-21       Impact factor: 4.123

Review 7.  Improving clinical trial readiness to accelerate development of new therapeutics for Rett syndrome.

Authors:  Helen Leonard; Wendy Gold; Rodney Samaco; Mustafa Sahin; Timothy Benke; Jenny Downs
Journal:  Orphanet J Rare Dis       Date:  2022-03-04       Impact factor: 4.123

Review 8.  Intellectual disability: dendritic anomalies and emerging genetic perspectives.

Authors:  Tam T Quach; Harrison J Stratton; Rajesh Khanna; Pappachan E Kolattukudy; Jérome Honnorat; Kathrin Meyer; Anne-Marie Duchemin
Journal:  Acta Neuropathol       Date:  2020-11-23       Impact factor: 17.088

Review 9.  Reviewing Evidence for the Relationship of EEG Abnormalities and RTT Phenotype Paralleled by Insights from Animal Studies.

Authors:  Kirill Smirnov; Tatiana Stroganova; Sophie Molholm; Olga Sysoeva
Journal:  Int J Mol Sci       Date:  2021-05-18       Impact factor: 5.923

10.  Phenotypic features in MECP2 duplication syndrome: Effects of age.

Authors:  Sarika U Peters; Cary Fu; Eric D Marsh; Tim A Benke; Bernard Suter; Steve A Skinner; David N Lieberman; Shannon Standridge; Mary Jones; Arthur Beisang; Timothy Feyma; Peter Heydeman; Robin Ryther; Daniel G Glaze; Alan K Percy; Jeffrey L Neul
Journal:  Am J Med Genet A       Date:  2020-11-10       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.